2008 Division Bibliography

Division of Cardiology

Northwestern University Feinberg School of Medicine

Bibliography

2008

Original Articles

Abraham WT, Burkhoff D, Nademanee K, Carson P, Bourge R, Ellenbogen KA, Parides M, Kadish AH. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Am Heart J 2008;156:641-648.

Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-356.

Ahmed A, Allman RM, Fonarow GC, Love TE, Zannad F, Dell'italia LJ, White M, Gheorghiade M. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 2008;14: 211-218.

Ahmed A, Lloyd-Jones DM. Poor outcomes and complex interactions of diabetes, sex, and age in chronic heart failure. Cardiol Rev 2008;25:1-8.

Albert CM, Quigg R, Saba S, Estes NA 3rd, Shaechter A, Subacius H, Howard A, Levine J, Kadish A. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J 2008;156:367-372.

Alexander D, Ou FS, Roe MT, Pollack CV, Ohman EM, Cannon CP, Gibler WB, Fintel DF, Peterson ED, Brown DL. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE). Am Heart J 2008;156:606-612.

Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillips L, Cochrane BB, Eaton CB, Greenland P, Hendrix S, Hsia J, Hunt JR, Jackson RD, Johnson KC, Kuller LH, Robinson J. Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study. Menopause 2008;15:639-647.

Arora R, Ulphani J, Villuendas R, Ng J, Harvey L, Thordson S, Inderyas F, Lu Y, Gordon D, Denes P, Greene R, Crawford S, Decker R, Morris A, Goldberger J, Kadish A. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium. Am J Physiol Heart Circ Physiol 2008;294:H134-H144.

Baggish AL, Lloyd-Jones DM, O’Donoghue M, Sakhuja R, Lainchbury JG, Richards AM, Januzzi JL. A clinical and biochemical score for mortality prediction in patients with acute dyspnea: derivation, validation, and incorporation into a bedside program. Heart 2008;94: 1032-1037.

Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, Szklo M, Lima JAC. Novel metabolic risk ractors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Athero-sclerosis) Study. J Am Coll Cardiol 2008;51:1775-1783.

Barac A, Campia U, Matuskey LA, Lu L, Panza JA. Effects of peroxisome proliferator-activated receptor-gamma activation with piglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypercholesterolemia or hypertension. Am J Cardiol 2008; 101:980-985.

Beller GA, Bonow RO, Fuster V. ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiovascular Training (COCATS 3). Revision of the 2002 COCATS training statement. J Am Coll Cardiol 2008; 51:335-338.

Beohar N, Erdogan AK, Lee DC, Sabbah HN, Kern MJ, Teerlink J, Bonow RO, Gheorghiade M. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol 2008; 52:13-16.

Berry JD, Dyer AR, Carnethon M, Tian L, Greenland P, Lloyd-Jones DM. Association of traditional risk factors with cardiovascular death across 0-10, 10-20, and >20 years’ follow-up in men and women. Am J Cardiol 2008;101:89-94.

Blair JE, Macarie C, Ruzyllo W, Bacchieri A, Valentini G, Bianchetti M, Pang PS, Harinstein ME, Sabbah HN, Filippatos GS, Gheorghiade M. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther 2008; 15:231-240.

Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M. Continental differences in clinical characteristics, manage-ment, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vaso-pressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol 2008;52:1640-1648.

Bonow RO. High speed myocardial perfusion imaging: dawn of a new era in nuclear cardiology? J Am Coll Cardiol Img 2008;1:164-166.

Bonow RO. Is appropriateness appropriate? J Am Coll Cardiol 2008;51:1290-1291.

Bonow RO. The 6th Annual Mario Verani, MD Memorial Lecture. Cardiovascular imaging: added value or added cost? J Nucl Cardiol 2008;15:170-177.

Bonow RO. Bicuspid aortic valves and dilated aortas: a critical review of the critical review of the ACC/AHA guidelines recommendations. Am J Cardiol 2008;102:111-114.

Bonow RO. Measuring quality in heart failure: do we have the metrics? Circ Cardiovasc Qual Outcomes 2008;1:9-11.

Bonow RO, Baker DW, Behal R, Bellande B, Gabel R, Gitman PA, Helstad CP, Linder JA, Manning W, McNeil BJ, Metersky M, Normand ST, O’Tooler M, Radford M, Wall EM, Wilson DF, Burstin H. Measure testing protocol for Physician Consortium for Performance Improvement performance measures. 2008. Available at www.ama-assn.org/ama1/pub/upload/mm/370/ pcpitestingprotocol.pdf.

Bonow RO, Carabello B, Chatterjee K, De Leon AC, Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise J. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Executive summary. J Am Coll Cardiol 200852:e1-e142.

Bonow RO, Masoudi FA, Rumsfeld JS, DeLong E, Estes NAM III, Goff DC Jr, Grady K, Green LA, Loth AR, Peterson ED, Pina IL, Radford MJ, Shahian DM. Classification of care metrics intended for performance measurement or quality improvement. Circulation 2008;118:2662-2666 and J Am Coll Cardiol 2008;52:2113-2117.

Brandimarte F, Blair JE, Manuchehry A, Fedele F, Gheorghiade M. Aldosterone receptor blockade in patients with left ventricular systolic dysfunction following acute myocardial infarction. Cardiol Clinics 2008;26:91-105.

Bucciarelli-Ducci C, Denes P, Holly TA, Wu E. Pseudo-Wellens T-waves in patients with suspected myocardial infarction: how cardiac magnetic resonance imaging can help the diagnosis. Int J Cardiol 2008;128:e68-71.

Burke MA, Mutharasan RK, Ardehali H. The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel. Circ Res 2008;102:164-176.

Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, Wen Y, Rapp JA, Kessler J. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008;299:925-936.

Cavalcante JL, Khan S, Gheorghiade M. EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan. Expert Rev Cardiovasc Ther 2008;6:1331-1338.

Campia U, Panza JA. Flavanol-rich cocoa a promising new diatary intervention to reduce cardiovascular risk in type 2 diabetes? J Am Coll Cardiol 2008;51:2150-2152.

Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev Med 2008;47:619-623.

Chung AK, Pang PS, Fonarow GC, Gheorghiade M. Acute Heart Failure Syndromes: Potential Strategies to Improve Post-discharge Outcomes. Curr Treat Options Cardiovasc Med 2008;10:349-357.

Collins S, Storrow AB, Kirk JD, Pang PS, Diercks DB, Gheorghiade M. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med 2008;51:45-57.

Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M. Fluid overload in acute heart failure:redistribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008;10:165-169.

Davidson CJ, Erdogan AK. Contrast media: procedural capacities and potential risks. Rev Cardiovasc Med 2008;9 (suppl 1):S24-S34.

De Lemos JA, Lloyd-Jones DM. Multiple biomarker panels for cardiovascular risk assessment. N Engl J Med 2008;358: 2172-2174.

De Luca L, Mebazaa A, Filippatos G, Parissis JT, Bohm M, Voors AA, Nieminen M, Zannad F, Rhodes A, El-Banayosy A, Dickstein K, Gheorghiade M. Overview of emerging pharmacologic agents for acute heart failure syndromes. Eur J Heart Fail 2008;10:201-213.

Dharmakumar R, Koktzoglou I. Tang R. Harris KR. Beohar N. Li D. Off-resonance positive contrast imaging of a passive endomyocardial catheter in swine. Phys Med Biol 2008;53:N249-257.

Dibs S, Ng J, Arora R, Passman R, Kadish A, Goldberger J. Spatiotemporal characterization in persistent human atrial fibrillation: multisite electrogram analysis and surface electrocardiographic correlations – a pilot study. Heart Rhythm 2008;5:686-693.

Eimer MJ, Wright JM, Wang EC, Kulik L, Blei A, Flamm S, Beahan M, Bonow RO, Abecassis M, Gheorghiade M. Frequency and significance of acute heart failure following liver transplantation. Am J Cardiol 2008;101:242-244.

Farmakis D, Filippatos G, Kremastinos DT, Gheorghiade M. Vasopressin and vasopressin antagonists in heart failure and hyponatremia. Curr Heart Fail Rep 2008;5:91-96.

Farmakis D, Filippatos G, Parissis J, Kremastinos DT, Gheorghiade M. Hyponatremia in heart failure. Heart Fail Rev 2008 Aug 29. [Epub ahead of print] PMID:18758941.

Fedak PWM, McCarthy PM, Bonow RO. Evolving concepts and techniques in mitral valve repair. Circulation 2008;117: 963-974.

Flaherty JD, Davidson CJ, Faxon DP. Percutaneous coronary intervention for myocardial infarction in patients with left ventricular dysfunction. Am J Cardio 2008;102: 38G-41G.

Flaherty JD, Udelson JE, Gheorghiade M, Wu E, Davidson CJ. Assessment of key targets for therapy in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol 2008;102:5-12.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Nunez E, Yancy CW, Young JB. A smoker's paradox in patients hospitalized for heart failure: findings from OPTIMIZE-HF. Eur Heart J 2008;29:1983-1991

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008;168:847-854.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure. Am J Cardiol 2008;102:1524-1529.

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 2008;52:190-199.

Fonarow GC, Abraham WT, Gheorghiade M, Cannon CP, Sackner-Bernstein JD, Udelson JE, Konstam MA. Role of beta-blocker therapy in the postmyocardial infarction patient with and without left ventricular dysfunction. Consensus guideline. Crit Pathw Cardiol 2008;2:239-246.

Fonarow GC, Flaherty JD, Gheorghiade M. Introduction to ACCORD-PMI: The Advisory Council on Care Optimization to Reduce Death Post-MI. Am J Cardiol 2008; 102:1-4.

Fonarow GC, Peacock WF,, Abraham WT, Amsterdam EA., Ander DS, Collins SP, Diercks DB, Dodge G, Filippatos G, Gaieski DF, Gheorghiade M, Gurney D, Hayes DO, Heistand B, Hollander JE,Holmes K, Januzzi JL Jr, Kirk JD, Levy P, Maisel A, Miller CD, Pang PS, Selby E, Storrow AB, Trupp RJ, Weintraub NL, Yancy CW. Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. Crit Pathw Cardiol 2008;7:83-86.

Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, Grundy SM, Jarratt MT, Krueger JG, Ridker PM, Stone N, Roberts WC. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008;102:1631-1643.

Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail 2008;10:70-77.

Gheorghiade M, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Valentini G, Sabbah HN. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol 2008;51:2276-2285.

Gheorghiade M, Filippatos GS, Fonarow GC, Anker SD. Nutritional supplementation with amino acids in cardiovascular and metabolic diseases: hypermetabolic syndrome as a therapeutic target. Introduction. Am J Cardiol 2008;101:1E-2E.

Gheorghiade M, Filippatos GS, Fonarow GC, Anker SD. Role of oral nutritional supplementation with amino acids in chronic diseases. Am J Cardiol 2008;101;1E-2E.

Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Greenland P, Rosenberg Y, O’Rourke RA, Shah PK, Smith SJ. Post-myocardial infarction β-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker and β-Blocker Therapy Post-MI (PACE-MI) Trial. Am Heart J 2008;155:455-464.

Goldberger JJ. Cain ME. Hohnloser SH. Kadish AH. Knight BP. Lauer MS. Maron BJ. Page RL. Passman RS. Siscovick D. Siscovick D. Stevenson WG. Zipes DP. American Heart Association/American College of Cardiology Foundation/ Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Heart Rhythm 2008;5:e1-e21; Circulation 2008;118:1497-1518; and J Am Coll Cardiol 2008;52:1179-1199.

Gould KL, Pan T, Loghin C, Johnson NP, Sdringola S. Reducing radiation dose in rest-stress cardiac PET/CT by single post-stress cine CT for attenuation correction: quantitative validation. J Nucl Med 2008;49:738-745.

Gordon L, Singh A, Prachand S, Lieberman E, Sun L, Burke MA, Naik TJ, Prasad S, Ardehali H. Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways. J Biol Chem 2008;284:2080-2087.

Greenland P. Changing of the guard: new editor for Archives of Internal Medicine. Arch Intern Med 2008;168: 2401.

Greenland P, Bonow RO. How low-risk is a coronary calcium score of zero? The importance of conditional probability. Circulation 2008;117:1627-1629.

Greenland P, Lloyd-Jones DM. Critical lessons from the ENHANCE trial. JAMA 2008;299:953-995.

Greenland P, Lloyd-Jones DM. Defining a rational approach to screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2008;52:330-332.

Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 2008;5: 1359-1363.

Harinstein ME, Berliner JI, Shah SJ, Taegtmeyer H, Gheorghiade M. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients. Am J Ther 2008;15:206-213.

Harinstein ME, Flaherty JD, Ansari AH, Robin J, Davidson CJ, Rossi J, Flamm SL, Blei AT, Bonow RO, Abecassis M, Gheorghiade M. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008;8:1523-1529.

Harinstein ME, Flaherty JD, Fonarow GC, Gheorghiade M. Directions for research in the post myocardial infarction patient with left ventricular dysfunction. Am J Cardiol 2008;102:57-61.

Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A. Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm. 2008;5:1517-1522.

Herzog CA, Mangrum M, Passman R. Sudden cardiac death in dialysis patients. Semin Dialysis 2008;21:300-307.

Ingelsson E, Gona P, Larson MG, Lloyd-Jones DM, Kannel WB, Vasan RS, Levy D. Evidence that treatment has altered the course of blood pressure progression and the relation of blood pressure to outcome. Arch Intern Med 2008;168:1450-1457.

Jacobson J. Passman R. Atrial fibrillation with iso-proterenol: teaching an old drug new tricks. J Cardiovasc Electrophysiol. 2008;19:471-472.

Jiang W, Hall SR, Moos M PW, Cao R Y, Ishii Satoshi, Ogunyankin KO, Melo LG, Funk CD. Endothelial cysteinyl leukotriene 2 receptor (CysLT2R) expression mediates myocardial ischemia-reperfusion. Am J Pathol 2008;172: 592-602.

Johnson NP, Denes P. The ladder diagram (a 100+ year history). Am J Cardiol 2008;101:1801-1804.

Johnson NP, Wu E, Bonow RO, Holly TA. Relation of exercise capacity and body mass index to mortality in patients with intermediate to high risk of coronary artery disease. Am J Cardiol 2008;102:1028-1033.

Johnson R, Lambers E, Hamada H, Bord E, Thorne T, Goukassian D, Krishnamurthy P, Rosen KM, Ahluwalia D, Zhu Y, Win G, Losordo DW, Kishore R. Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res 2008;102:107-117.

Jones DW, Peterson ED, Bonow RO, Masoudi FA, Fonarow GC, Smith SC, Solis P, Girgus M, Hinton P, Leonard A, Gibbons RJ. Translating research into practice for healthcare providers: the American Heart Association’s strategy for building healthier lives free of cardiovascular disease and stroke Circulation 2008;118:687-696.

Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 2008;45:530-544.

Kadish AH. Can ICDs prevent sudden cardiac death effectively in patients with hypertrophic cardiomyopathy? Nat Clin Pract Cardiovasc Med 2008 [Epub ahead of print].

Kadish AH, Reiffel JA, Naccarelli GV, DiMarco JP. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol 2008;102:29G-37G.

Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 2008; 18:33-37.

Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld B, Pasternak RC, Chae CU. C-reactive protein levels vary by ethnicity in the Study of Women’s Health Across the Nation (SWAN). Clin Chem 2008;54:1027-1037.

Kirk JD, Filippatos G, Gheorghiade M, Pang PS, Levy P, Amsterdam EA, Peacock WF, Fonarow GC. Acute heart failure treatment. Crit Pathw Cardiol 2008;7:103-110.

Kizilbash MA, Daviglus ML, Dyer AR, Garside DB, Hankinson AL, Yan LL, Tian L, Van L, Wang R, Greenland P. Relation of heart rate with cardiovascular disease in normal-weight individuals: the Chicago Heart Association Detection Project in Industry. Prev Cardiol 2008;11:141-147.

Klein L, Massie BM, Leimberger JD, O’Connor CM, Pina IL, Adams KF, Califf RM, Gheorghiade M. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival. Circ Heart Fail 2008;1:25-33.

Klein L, O’Connell JB. Thromboembolic risk in the patient with heart failure. Curr Treat Options Cardiovasc Med 2007; 9:310-317.

Kumar A, Prineas RJ, Arnold AM, Psaty BM, Furberg CD, Robbins J, Lloyd-Jones DM. Prevalence, prognosis and implications of isolated minor non-specific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study. Circulation 2008;118:2790-2796.

LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Newman AB, Kooperberg CL, Black H, Curb JD, Greenland P, Woods NF. Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci 2008;63:369-375.

Lainscak M, Filippatos GS, Fonarow GC, Anker SD. Cachexia: common, deadly with an urgent need for precise definition and new therapies. Am J Cardiol 2008;101:8E-10E.

Lin D, Ilkhanoff L, Gerstenfeld E, Dixit S, Beldner S, Bala R, Garcia F, Callans D, Marchlinski FE. Twelve-lead electrocardiographic characteristics of the aortic cusp region guided by intracardiac echocardiography and electroanatomic mapping. Heart Rhythm 2008;5:663-669.

Losordo DW. Angiogenesis: an integrative approach from science to medicine (Book Review). N Engl J Med 2008;359: 2505-2506.

Losordo DW, Kishore R. A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009;53:10-12.

Lötjönen JM, Järvinen VM, Cheong B, Wu E, Kivistö S, Koikkalainen JR, Mattila JJ, Kervinen HM, Muthupillai R, Sheehan FH, Lauerma K. Evaluation of cardiac biventricular segmentation from multiaxis MRI data: a multicenter study. J Magn Reson Imaging 2008;28:626-636.

Maganti K, Rajamannan NM. Slowing the progression of aortic stenosis. Curr Treat Options Cardiovasc Med 2008;10: 18-26.

Maganti K, Rigolin VH, Bonow RO. Valvular heart disease in women. Curr Cardiovasc Risk Rep 2008;2:217-226.

Maron BJ, Bonow RO, Salberg L, Roberts WC, Braunwald E. The first patient clinically diagnosed with hypertrophic cardiomyopathy. Am J Cardiol 2008; 102:1418-1420.

Masoudi FA, Bonow RO, Brindis RG, Cannon CP, DeBuhr J, Fitzgerald S, Heidenreich PA, Ho KKL, Krumholz HM, Leber C, Magid DJ, Nilasena DS, Rumsfeld JS, Smith SC Jr, Wharton TP Jr. ACC/AHA 2008 statement on performance measurement and reperfusion therapy: a report of the ACC/AHA Task Force on Performance Measures. Circula-tion 2008;118:2649-2661 and J Am Coll Cardiol 2008;52: 2100-2112.

Matarieh A, Harinstein ME, Salanitri J, Maganti K. Adult cardiac cystic lymphangiectasia of the right atrium. Echocardiogr 2008;25:772-777.

McCarthy PM, McGee EC, Rigolin VR, Zhao Q, Subacius MA, Huskin AL, Underwood S, Kane BJ, Mikati I, Gang G, Bonow RO. Initial clinical experience with Myxo-ETlogix mitral valve repair ring. J Thorac Cardiovasc Surg 2008;136:73-81.

McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe M, Domanchuk K, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009;301:165-174.

McGee EC Jr, Cotts W, Tambur AR, Friedewald J, O’Connell J, Wallace S, McCarthy PM. Successful bridge to transplant in a highly sensitized patient with a complicated pocket infection. J Heart Lung Transplant 2008;27:568-571.

McManus DD, Shah SJ, Fabi MR, Rosen A, Whooley MA, Schiller NB. Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study. J Am Soc Echocardiogr 2008 Dec 10. [Epub ahead of print]

Mebazaa A, Gheorghiade M, Pina IL, Harjola VP, Hollenberg SM, Follath F, Rhodes A, Plaisance P, Roland E, Nieminen M, Komajda M, Parkhomenko A, Masip J, Zannad F, Filippatos G. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008;36(suppl):S129-133.

Newman J, Grobman WA, Greenland P. Combination polypharmacy for cardiovascular disease prevention in men: a decision analysis and cost-effectiveness model. Prev Cardiol 2008;11:36-41.

O'Connell JB, McCarthy PM, Sopko G, Filippatos GS, Piña IL, Konstam MA, Young JB, Miller LW, Mehra MR, Roland E, Blair JE, Farrar DJ, Gheorghiade M. Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design. Heart Fail Rev 2008. [Epub ahead of print] PMID:18548344

O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2008;156:662-673.

Ogunyankin KO, Day AG, Lonn E. Cardiac function stratification based on echocardiographic or clinical markers of left ventricular filling pressures predicts death and hospitalization better than stratification by ventricular systolic function alone. Echocardiogr 2008;25:169-181.

Ortiz-Perez JT, Rodriguez J, Meyers SN, Lee DC, Davidson C, Wu E. Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging. J Am Coll Cardiol Img 2008;1:282-292.

Pang PS, Cleland JG, Teerlink JR, Collins SP, Lindsell CJ, Sopko G, Peacock WF, Fonarow GC, Aldeen AZ, Kirk JD, Storrow AB, Tavares M, Mebazaa A, Roland E, Massie BM, Maisel AS, Komajda M, Filippatos G, Gheorghiade M. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008;29:816-824.

Pang PS, Tavares M, Collins SP, Cleland JG, Hollander J, Nieminen M, Miller C, Courtney DM, Kirk JD, Masip J, Parkhomenko A, Macarie C, Peacock WF, Spinar J, Nowak R, Raev D, Storrow AB, Spisak V, Hamdy A, Mebazaa A, Gheorghiade M. Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study. Am J Ther 2008;15:299-303.

Pasini E, Aquilani R, Dioguardi FS, D’Antona G, Gheorghiade M, Taegtmeyer H. Hypercatabolic syndrome: molecular basis and effects of nutritional supplementation with amino acids. Am J Cardiol 2008;101:11E-15E.

Passman R, Banthia S, Galvez D, Sheldon T, Kadish A. The effects of rate-adaptive atrial pacing versus ventricular backup pacing on exercise capacity in patients with left ventricular dysfunction. PACE 2009;32:1-6.

Pavri BB, Hillis MB, Subacius H, Brumberg GE, Schaechter A, Levine JH, Kadish AH. Prognostic value and temporal behavior of the planar QRS-T angle in patients with nonischemic cardiomyopathy. Circulation 2008;117:3181-3186.

Pletcher MJ, Greenland P. Coronary calcium scoring and cardiovascular risk: the SHAPE of things to come. Arch Intern Med 2008;168:1027-1028.

Rajasingh J, Lambers E, Hamada H, Bord E, Thorne T, Goukassian I, Krishnamurthy P, Rosen KM, Ahluwalia D, Zhu Y, Qin G, Losordo DW, Kishore R. Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res 2008;102:e107-117.

Rapp JA, Gheorghiade M. Role of neurohormonal modulators in heart failure with relatively preserved systolic function. Cardiol Clinics 2008;26:23-40.

Reddy VK, Gapstur SM, Prineas R, Colangelo LA, Ouyang P, Kadish AH. Ethnic differences in ST height in the Multi-Ethnic Study of Atherosclerosis. Ann Noninvasive Electrocardiol 2008;13:341-351.

Rehman S, Lloyd-Jones DM, Martinez-Rumayor A, Januzzi JL, Jr. Inflammation, amino-terminal pro-brain natriuretic peptide, and mortality risk in dyspneic patients. Am J Clin Path 2008;130:305-311.

Robin J, Fintel JB, Pikovskaya O, Flaherty J, Cilley, Davidson C. Multiple myeloma presenting with high output heart failure and improving with anti-angiogensis therapy: a case series and review of the literature. J Med Case Rep 2008;2:229.

Robin J, Meyers S, Nahlawi M, Puthumana J, Lomasney JW, Mehlman D, Rigolin V, Davidson CJ. Accelerating restrictive cardiomyopathy after liver transplantation in a patient with familial amyloidotic polyneuropathy: a case report. J Med Case Rep 2008;2:35.

Robinson JG, Schmeltz LR, Stone NJ. Type 2 diabetes and cardiovascular risk. Med Clin NA 2008;92:37-48.

Roncalli J, Carrie D, Fauvel JM, Losordo DW. A "hawk's beak" to identify the new transient midventricular Tako-Tsubo syndrome. Int J Cardiol. 2008;127:e179-180,

Roncalli JG, Tongers J, Renault MA, Losordo DW. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Biotechnol 2008;26:276-283.

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Megis J, Moy C, Nichol G, O'Donnell CJ, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics: 2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.

Rosengart TK, Feldman T, Borger MA, Vassiliades T, Gillinov M, Vahanian A, Bonow RO, O'Neill W. American Heart Association statement on percutaneous and minimally invasive valve procedures. Circulation 2008;117:1750-1767.

Rossi JS, Flaherty JD, Fonarow GC, Nunez E, Stough WG, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, Yancy CW, Young JB, Davidson CJ, Gheorghiade M. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF. Eur J Heart Fail 2008;10:1215-1223.

Rossouw JE, Pettinger M, Greenland P, Kooperberg C, Robinson J, Lloyd-Jones DM, Hsia J, Hendrix S, Bray P, Cushman M. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the Women’s Health Initiative trials of hormone therapy. Arch Intern Med 2008;168:2245-2253.

Rubenstein JC, Ortiz JT, Wu E, Kadish A, Passman R, Bonow RO, Goldberger JJ. The use of periinfarct contrast-enhanced cardiac magnetic resonance imaging for the prediction of late postmyocardial infarction ventricular dysfunction. Am Heart J 2008;156:498-505.

Ruifrok WP, deBoer RA, Iwakura A, Silver M, Kusano K, Tio RA, Losordo, DW. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Vasc Med 2009;14:29-36.

Scuteri A, Tesauro M, Rizza S, Iantorno M, Federici M, Lauro D, Campia U, Turriziani M, Fusco A, Cocciolillo G, Lauro R. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008;18:349-356.

Shah SJ, Bardo DM, Sugeng L, Weinert L, Lodato JA, Knight BP, Lopez JJ, Lang RM. Real-time three-dimensional transesophageal echocardiography of the left atrial appendage: initial experience in the clinical setting. J Am Soc Echocardiogr 2008;21:1362-1368.

Shah SJ, Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 2008;300:431-433.

Shah SJ, Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, Foster E, Chatterjee K, Michaels AD. Physiology of the third heart sound: novel insights from tissue Doppler imaging. J Am Soc Echocardiogr 2008;21:394-400.

Shah SJ, Nakamura K, Marcus GM, Gerber IL, McKeown BH, Jordan MV, Huddleston M, Foster E, Michaels AD. Association of the fourth heart sound with increased left ventricular end-diastolic stiffness. J Card Fail 2008;14:431-436.

Shah SJ, Thenappan T, Rich S, Archer SL, Gomberg-Maitland M. Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. Circulation 2008;117:2475-2483.

Shah SJ, Waters DD, Barter P, Kastelein JJP, Shepherd J, Wenger NK, DeMicco D, Breazna A, LaRosa JC. Intensive lipid-lowering with atorvastatin for secondary prevention in patients who have undergone coronary artery bypass surgery. J Am Coll Cardiol 2008;51:1938-1943.

Sibs S, Ng J, Arora R, Passman R, Kadish A, Goldberger J. Spatiotemporal characterization of atrial activation in persistent human atrial fibrillation: multisite electrogram analysis and surface electrocardiographic correlations. A pilot study. Heart Rhythm 2008;5:686-693.

Stone NJ. Low-fat versus Mediterranean-style dietary intervention after first myocardial infarction. Curr Atheroscler Rep 2008;10:457-458.

Stone NJ. Nonpharmacologic management of mixed dyslipidemia associated with diabetes mellitus and the metabolic syndrome: a review of the evidence. Am J Cardiol 2008;102:14L-18L.

Stone NJ. The long-term effect of lifestyle interventions to prevent diabetes. Curr Atheroscler Rep 2008;10:458-459.

Straface G, Aprahamian T, Flex A, Gaetani E, Biscetti F, Smith RC, Pecorini G, Pola E, Angelini F, Stigliano E, Castellot JJ, Jr., Losordo DW, Pola R. Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration. J Cell Mol Med 2008, July 25 [E-pub ahead of print].

Sui X, Gheorghiade M, Zannad F, Young JB, Ahmed A. A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol. 2008;129:93-99.

Sun L, Shukair S, Naik TJ, Moazed FArdehali H. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinase I and II. Mol Cell Biol 2008;28:1007-1017.

Sundaram S, Carnethon M, Polito K, Kadish AH, Goldberger JJ. Autonomic effects on QT-RR interval dynamics after exercise. Am J Physiol Heart Circ Physiol 2008;294:H490-H497.

Taegtmeyer H, Harinstein ME, Gheorghiade M. More than bricks and mortar: comments on protein and amino acid metabolism in the heart. Am J Cardiol 2008;101:3E-7E.

Tongers J, Roncalli JG, Losordo DW. Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. Circulation 2008;18:9-16.

Udelson JE, Orlandi C, Ouyang J, Krasa H, Zimmer CA, Frivold G, Haught WH, Meymandi S, Macarie C, Raef D, Wedge P, Konstam MA, Gheorghiade M. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial. J Am Coll Cardiol 2008;,52:1540-1545.

Vashist A, Bonow RO. Screening for coronary atherosclerosis with coronary calcium scoring: the “Shape” of things to come? J Nucl Cardiol 2008;15:162-169.

Vidula H, Tian L, Liu K, Criqui MH, Ferrucci L, Pearce WH, Greenland P, Green D, Tan J, Garside DB, Guralnik J, Ridker PM, Rifai N, McDermott MM. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med 2008;148:85-93.

Villuendas R, Kadish AH. Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed. Prog Cardiovasc Dis 2008;51:128-134.

Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC Jr, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA 2008;299:2656-2666.

Wang NC, Rubenstein JC, Ilkhanoff L, Flaherty JD, Jacobson JT. Veiled villain. Am J Med 2008;121:864-867.

Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, Shi X, Pan L, Rampersaud E, Shen H, Kim JD, Subramanya AR, Steinle NI, Parsa A, Ober CC, Welling PA, Chakravarti A, Weder AB, Cooper RS, Mitchell BD, Shuldiner AR, Chang YP. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009;106:226-231.

Wasserstron JA, Kapur S, Jones S, Faruque T, Sharma R, Kelly JE, Pappas A, Ho W, Kadish AH, Aistrup GL. Characteristics of intracellular Ca2+ cycling in intact rat heart: a comparison of sex differences. Am J Physiol Heart Circ Physiol 2008;295:H1895-H1904.

Weinberg KM, Denes P, Kadish AH, Goldberger JJ. Development and validation of diagnostic criteria for atrial flutter on the surface electrocardiogram. Ann Noninvasive Electrocardiol. 2008;13:145-154.

Williams E, Shah SJ, Ali S, Na B, Schiller NB, Whooley MA. C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease. Eur J Heart Fail 2008;10:63-69.

Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones DM, Klocke FJ, Bonow RO. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008;94:730-736.

Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, She L, Sun JL, Young JB, Fonarow GC. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol 2008;51:1675-1684.

Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, She L, Sun JL, Yancy CW, Fonarow GC. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 2008;101:223-230.

Books

Mebazza A, Gheorghiade M, Zannad FM, Parrillo JE. Acute Heart Failure. London: Springer-Verlag 2008, pp 931.

Lloyd-Jones DM, McKibbin KM, eds. AMA Complete Guide to Prevention and Wellness. Hoboken, NJ, John Wiley & Sons 2008, pp 380.

Stone N.J, Blum CB. Management of Lipids in Clinical Practice, 7th Edition. Professional Communications, Inc. 2008, pp 416.

Chapters

Benzuly K, Davidson CJ, Pang J. Coronary interventional equipment and techniques: coronary stenting. In: Cath SAP 3. Washington: American College of Cardiology 2008,568-577.

Bonow RO. Foreword. In: Hutchinson S. Pericardial Diseases: Clinical Diagnostic Imaging Atlas. Philadelphia: Saunders/Elsevier 2009,vii.

Chicos AB, Kadish AH. Arrhythmia in acute heart failure. In: Mebazza A, Gheorghiade M, Zannad FM, Parrillo JE, eds. Acute Heart Failure. London. Springer-Verlag 2008, 221-236.

Davidson CJ, Erdogan A. Fundamentals of cardiac catheterization: contrast agents, reactions, and nephropathy. In: Cath SAP 3. Washington: American College of Cardiology 2008,211-219.

Johnson NP, Moorman AJ, Pang PS, Collins SP, Eimer MJ, Gheorghiade M. Early hedical management of acute heart failure syndromes (AHFS). In: Baliga R, Pitt B, Givertz M, eds. Management of Heart Failure. London: Springer-Verlag, 2008,129-158.

Klein L, Bonow RO. Diabetes mellitus and diastolic heart failure. In: Klein AL, Garcia MJ,eds. Diastology: Clinical Approach to Diastolic Heart Failure. Philadelphia: Elsevier Science 2008,333-342.

Lloyd-Jones DM. Ischemic heart disease risk. In: Izzo JL Jr, Siac DA, Black HR, eds. Hypertension Primer, 4th Edition. Dallas, TX: American Heart Association 2008, 249-253.

Mebazza A, Gheorghiade M, Zannad FM, Parrillo JE. Definitions of acute heart failrue syndromes. In: Mebazza A, Gheorghiade M, Zannad FM, Parrillo JE, eds. Acute Heart Failure. London: Springer-Verlag 2008,5-6.

Orlandi C, Brandimarte P, Gheorghiade M. Vasopressin antagonists in acute heart failure syndromes. In: Mebazza A, Gheorghiade M, Zannad FM, Parrillo JE, eds. Acute Heart Failure. London: Springer-Verlag, 2008, 621-625.

Passman R, Mangrum M, Herzog C. Sudden cardiac death in dialysis patients. In: Rose, BD, ed. UpToDate, Wellesley, MA, 2007.

Stone NJ, Lloyd-Jones DL. Framingham risk scoring or risk factor counting: Which is more sensitive and how do I use this information to determine patient-specific lipid goals? In: Toth P, Sica D, eds. Clinical Challenges in Dyslipidemia Management Ashland, OH: Clinical Publishing 2008,17-25.

Abstracts

Albert NM, Fonarow GC, Yancy CW, Curtis A, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, Mehra M, O'Connor C, Reynolds D, Walsh MN. Influence of advance practice nurse and dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: IMPROVE HF findings. J Card Fail 2008;14:S101

Arora R, Villuendas R, Aistrup G, Ng J, Gilchrist A, Schliamser J, Wasserstrom JA, Gordon D, Dean D, Zhou R, Kadish A. Targeted G-protein inhibition in the posterior left atrium–a novel gene-based approach to selectively inhibit parasympathetic signaling in the left atrium. Heart Rhythm 2008;5:S55.

Bahekar AA, Rodriguez-Palomares JF, Wu E. Parallel acquisition to improve temporal resolution in the rapid detection of myocardial infarction: comparison of image quality and artifacts. J Cardiovasc Magn Res 2008;10:15.

Bakhos L, Holly TA, Wu E, Lee DC. Evaluation of ischemic myocardial stunning following adenosine vasodilator stress using cardiac magnetic resonance imaging. J Nucl Cardiol 2008;15:S10-11.

Beohar, N, Erdogan A, Harinstein M, Meyers SN, Gu J, Pieper K, Davidson CJ. A meta-analysis evaluating long-term safety and efficacy of drug eluting stents compared to bare-metal stents for off-label indications. J Am Coll Cardiol 2008;51:A179

Beohar N, Davidson CJ, Erdogan A, Harinstein M, Meyers SN, Pieper K. United States and outside US outcomes of the off-label use of bare metal stents compared to drug eluting stents: a meta-analysis. Circulation 2008;118 (suppl 2): S1051-S1052.

Berry JD, Dyer AR, Cai X, Garside DB, Lloyd-Jones DM. Differential associations of individual risk factors with lifetime risks for cardiovascular disease in blacks and whites. Circulation 2008;117:e270.

Berry J, Passman R, MD, Prineas RJ, van Horn L, Tinker L, Wu LL, Snetselaar L, Goldberger J, Liu K, Lloyd-Jones DM. Fish and omega-3 fatty acid intake and incident atrial fibrillation: the Women’s Health Initiative. Heart Rhythm 2008;5:S22.

Betti I, Castelli G, Barchielli A, Boscherini V, Messeri G, Nistri R, Gheorghiade M, De Luca L, Maisel A, Zuppiroli A. The prevalence of asymptomatic left ventricular dysfunction in subjects at risk of heart failure. Results of the PROBE-HF study. J Am Coll Cardiol 2008;51:A51.

Betti I, Castelli G, Barchielli A, Boscherini V, Messeri G, Nistri R, Gheorghiade M, De Luca L, Maisel A, Zuppiroli A. The role of NT-proBNP and echocardiography for screening asymptomatic left ventricular dysfunction in subjects at risk of heart failure: results of the PROBE-HF study. J Am Coll Cardiol 2008;51:A51.

Blair J, Burnett JC, Konstam MA, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Gheorghiade M. Prognostic value and changes in renal function in patients admitted with acute heart failure: results from the EVEREST program. Eur Heart J 2008; 29 (suppl):270.

Blair J, Zannad F, Konstam MA, Cook T, Burnett JC, Grinfield L, Maggioni A, Swedberg K, Udelson JE, Gheorghiade M. Continental differences in baseline characteristics and outcomes in patients hospitalized with worsening heart failure and systolic dysfunction: results from the EVEREST program. Eur Heart J 2008;29 (suppl): 853.

Burke MA, Ochenjele G, Fernandez RP, Prasad SV, Ardehali H Snf1-related kinase is upregulated in the ischemic heart and regulates cellular metabolism and death. Circ Res 2008;103:P57.

Burke MA, Ochenjele G, Fernandez RP Prasad SV, Ardehali H. Snf1-related kinase is upregulated in the ischemic heart and regulates cellular metabolism and death. Circulation 2008;118 (suppl 2):S289

Burke MA, Wu R, Naik T, Prasad SV, Ardehali H The mitochondrial ATP-binding cassette protein 2 is overexpressed in ischemic heart disease and regulates cellular ROS levels. Circ Res 2008;103:P57.

Evans NS, Lloyd-Jones DM, Schreiner PJ, Gidding SS, Liu K, Carnethon MR. Diet, BMI, and fitness and the development of low high-density lipoprotein cholesterol (HDL-C) levels: CARDIA. Am J Epidemiol 2008;167:S69.

Flaherty JD, Rossi JS, Davidson CJ, Nunez E, Gattis Stough W, Abraham WT, Alber NM, Greenberg BH, O'Connor CM, Yancy CW, Young JB, Fonarow GC, Gheorghiade M. Influence of coronary angiography on therapy utilization and survival in acute heart failure: a report from the OPTIMIZE-HF registry. Am J Cardiol 2008:102:25I.

Gheorghiade M, Zimmer C, Burnett J, Grinfeld L, Maggioni AP, Swedberg K, Zannad F, Fonarow GC, Cook T, Konstam M. Relationship between body weight change following hospital discharge and risk for death/rehospitalization. Eur Heart J 2008;29 (suppl):269.

Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Rosenberg Y, O’Rourke RA Shah PK, Smith S. Are beta-blockers underdosed following acute myocardial infarction? Circulation 2008;118 (suppl 2):S968

Godreau A, Liu K, Lloyd-Jones DM, Hulley S, Lewis CE, Jacobs D, Chan C, Greenland P, Dyer A. Cross-sectional association of cardiovascular risk factors with subclinical atherosclerosis in different vascular beds: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circulation 2008;117:e286.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis A, Gattis Stough W, Gheorghiade M, McBride ML, Mehra M, O'Connor C, Reynolds D, Walsh MN. Comparison of medical treatment in outpatients receiving device therapy for systolic dysfunction: a report from IMPROVE HF. J Card Fail 2008;14:S94.

Huang C-C, Fornage M, Lloyd-Jones DM, Wei GS, Boerwinkle E, Liu K. Association of PCSK9 gene variants with longitudinal LDL-cholesterol levels: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circulation 2008;118 (suppl 2):S1101-1102.

Huang C-C, Liu K, Rajamannan N, Du P, Lin S, Burke G, Shea S, Szklo M, Watson K, Johnson C, Lloyd-Jones D. A genomic signature of atherosclerosis among individuals with low Framingham risk score: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2008;118 (suppl 2):S1083.

Huffman M, Berry JD, Dyer AR, Garside DB, Cai X, Daviglus ML, Lloyd-Jones DM. Lifetime risk for developing heart failure by sex and race at selected ages in multiple cohorts: Cardiovascular Lifetime Risk Pooling Project. Circulation 2008;118 (suppl 2):S1092.

Ichikawa Y, Potini V, Sun L, Mutharasan RK, Ardehali H. Mitochondrial ATP-binding cassette protein-1 (mABC1) plays a role in mitochondrial iron homeostasis and protein export. Circulation 2008;118 (suppl 2):S320.

Jacobson JT, Ilkhanoff L, Lin D. Focal ventricular tachycardia originating from a papillary muscle remote from scar in a patient with a history of subendocardial resection of anteroapical aneurysm. Heart Rhythm 2008;5 (suppl):S306.

Johnson R, Krishnamurthy, Lambers E, Sekiguchi H, David CJ, Thorne T, Qin G, Losordo DW, Kishore R. Derivation of Multipotent stem cells from epigenetically modified endothelial progenitor cells. Circulation 2008;118 (suppl 2):S392

Jujo K, Ii M, Sekiguchi H, Hamada H, Thorne T, Klachko E, Clarke T, Ito A, Misener S, Renault M-A, Losordo DW. Bone marrow MMP-9 expression mediates therapeutic effect of selective CXCR4 antagonist AMD 3100 on myocardial infarction. Circulation 2008:118 (suppl 2):S536.

Kinobe RT, Simpson JA, , Brunt KR, Hall SR, Ballantyne L, Ogunyankin KO, Ward C, Melo LG. Kinobe RT, Simpson JA, Brunt KR, Hall SR, Ballantyne LL, Ogunyankin KO. Heme oxygenase-1 attenuates isoproterenol-induced cardiac hypertrophy in vivo. FASEB J. 2008;22:970.

Klein L, Greenland P, Chan C, Tandri H, Bluemke DA, Prineas RJ. Prolonged QRS duration is associated with abnormal left ventricular function, but not with subclinical atherosclerosis in adults without clinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA) study. Circulation 2008;118 (suppl 2):S196

Kucharski T, Khan M, Holly T, McDonald N, Spies S. Prone vs. supine. Reducing bowel activity. J Nucl Med. 2008;49 (suppl 1):432P.

Lee DC, Johnson NP, Harris KR. The relationship between signal intensity and myocardial gadolinium concentration for three MR perfusion pulse sequences: implications for measuring absolute myocardial blood flow. J Cardiovasc Magn Res. 2008;10:21.

Lee DC, Johnson NP, O'Hara K, Harris KR. Correcting the underestimation of absolute myocardial blood flow by magnetic resonance perfusion imaging. Circulation 2008;118 (suppl 2):S645-646.

Levy P, Nandyal D, Sun, JL, Pieper K, Welch R, Ghali J, Gheorghiade M, O’Connor C, Fonarow G. Does aspirin use adversely influence intermediate term outcomes for hospitalized heart failure patients who are treated with angiotensin converting enzyme inhibitors or angiotensin receptor blockers? Findings from Optimize-HF. Circulation 2008;118 (suppl 2):S714.

Makati K, Madias C, Manuchehry A, Montevecchi M, Passman R, Estes III M, Link M. Patients with long QT syndrome and implantable cardioverter defibrillators have a high incidence of therapy for potentially life threatening arrhyhmia. Heart Rhythm 2008;5:S293.

Malaisrie SC, McCarthy PM, McGee EC, Lee R, Rigolin V, Davidson CJ, Rajamannan N, Bonow RO. Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis: implications for transcatheter aortic valve implantation. Circulation 2008;118 (suppl 2):S703.

Manuchehry A, Blair JE, Keller M, Goonewardena SN, Puthumana J, Gheorghiade M. Use of hand-carried ultrasound, clinical assessment, and BNP to estimate abnormal left ventricular filling pressures in inpatients referred for right heart catheterization. J Am Coll Cardiol 2008;51:A103.

Manuchehry A, Montevecchi M, Kadish A, Passman R. Mechanisms of ventricular tachyarrhythmias in patients receiving an implantable cardioverter-defibrillator for primary versus secondary prophylaxis indications. Heart Rhythm 2008;5:S277.

McDermott MM, Dyer A, Liu K, Guralnik JM, Ades P, Ferrucci L, Nelson M, Lloyd-Jones D, Pearce W, Van Horn L, Criqui MH. Benefits of strength training and supervised treadmill exercise on walking performance for persons with peripheral arterial disease with and without intermittent claudication symptoms. Circulation 2008;118 (suppl 2):S905.

Mehrotra AK, Hampole CV, Goonewardena SN, Bell GW, Blair JE, Agarwal R, Gheorghiade M, Woodruff J. NT-proBNP levels are lower in patients admitted with acute decompensated heart failure that have metabolic syndrome than those without. J Card Fail 2008;14:S36.

Montevecchi MV, Rubenstein JC, Manuchehry A, Goldberger JJ, Passman R. Does inpatient status at the time of defibrillator implantation affect survival? Heart Rhythm 2008;5:S190.

Mutharasan RK, Dore LC, Kong B, Naik T, Ardehali H. MicroRNA-210 is upregulated in hypoxic cardiomyocytes. Circ Res 2008;103:P180.

Ogunyankin KO, Day AG, Londry CC, Jiang X. Does a calcium channel blocker-based hypertension treatment cause a greater improvement in echocardiographic parameters than diuretic-based treatment in hypertensive subjects treated to normal blood pressure goal? J Am Soc Echocardiogr 2008;21:593.

Ogunyankin KO, Saluja J, Day AG, Severe diastolic dysfunction in non-hospitalized patients is associated with unexpectedly high mortality. J Am Coll Cardiol 2008;51:A98.

Ortiz J, De Carat T, Meyers S, Bellera N, Garcia A, Delgado V, Sitges M. Davidson CJ, Betriu A, Wu E. Does door-to-balloon time matter so much? A combined angiographic and magnetic resonance imaging evalulation. Eur Heart J 2008; 29 (suppl):137.

Ortiz-Perez JT, Betriu A, Meyers SN, Delgado V, Perea RJ, de Caralt T, Sitges M, Masotti M, Brugada J, Donoso L, Davidson C, Wu E. When door-to-balloon time becomes key for myocardial salvage. Circulation 2008;118 (suppl 2):S1077.

Pang PS, Gheorghiade M, Burnett J, Maggioni AP, Swedberg K, Zannad F, Zimmer C, Krasa HB, Ouyang J, Konstam M. Effects of tolvaptan, a vasopressin V2 antagonist, on patient assessed dyspnea related to time after hospital admission in the EVEREST trial. Eur Heart J 2008;29 (suppl):45.

Renault M-A, Roncalli J, Tonbers J, Hamada H, Thorne T, Misener S, Ito A, Clarke T, Millay M, Scarpelli A, Klyachko E, Losordo DW. Gli2 and Gli3 are over-expressed in the ischemic tissue and participate in ischemia-induced angiogenesis and myogenesis. Circulation 2008;118 (suppl 2):S551.

Renault M-A, Roncalli J, Tongers J, Misener S, Thorne T, Ito A, Clarke T, Millay M, Kamide C, Klyachko E, Losordo DW. The sonic hedgehog transcription factor Gli3 modulates ischemia-induced angiogenesis. Circulation 2008;118 (suppl 2):S518.

Rodriguez Palomares JF, Ortiz JT, Lee DC, Wu E. Differences in dynamic changes in acute and chronic infarct size after bolus gadolinium injection. J Cardiovasc Magn Res 2008;10:A151.

Rodriguez Palomares JF, Ortiz JT, Lee DC, Wu E. Microvascular obstruction over time as a predictor for left ventricular remodeling. J Cardiovasc Magn Res 2008;10: A14.

Rodriguez Paomares JF, Ortiz JT, Lee DC, Wu E. Micro-vascular obstruction over time as a predictor for left ventricular remodeling. Eur Heart J 2008;29 (suppl):375.

Rodriguez Palomares JF, Wu E, Puthumana J. Rapid evaluation of left atrial volumes using CMR and its relation with left ventricular diastolic dysfunction. J Cardiovasc Magn Res 2008;10:A314.

Roncalli J, Renault M-A, Tongers J, Li L, Jujo K, Thorne T, Misener S, Kamide C, Klyachko E, Ii M, Losordo DW. Enhancement of sonic hedgehog-induced cardiac functional recovery is augmented by CXCR4 antagonist via MMP-9-dependent pathway after myocardial infarction. Circulation 2008;118 (suppl 2):S487.

Rubenstein J, Lee D, Wu E, Kadish A, Passman RS, Golderger JJ. A comparison of cardiac MRI peri-infarct border zone quantification strategies for the prediction of ventricular tachycardia inducibility. Circulation 2008;118 (suppl 2):S832-833.

Rubenstein JC, Wu E, Ilkhanoff L, Jacobson J. Radiofrequency ablation lesions demonstrated by magnetic resonance. Heart Rhythm 2008;5:S48.

Schliamser J, Arora R, Villuendas R, Benefield B, Harris K, Gordon D, Shade G, Aistrup G, Green R, Goldberger J, Kadish A, Ng J. Beta adrenergic inhibition induces changes in activation patterns in pulmonary veins and posterior left atrium in a canine model of heart failure. Heart Rhythm 2008;5:S55.

Schliamser J, Kadish A, Subacius H, Shalaby A, Schaechter A, Levine J, Goldberger J. Follow-up left ejection fraction in the DEFINITE trial population predicts outcome regardless of cardioverter-defibrillator status. J Am Coll Cardiol 2008; 51:A19.

Shah AP, Beohar N, Youngquist S, Josephson G, Ros-borough JP, Niemann JT. Endogenous thymosin increases during acute myocardial ischemia. J Am Coll Cardiol 2008; 51:A179.

Shah SJ, Decara JM, Kurina, LM, Pollard H, Collins, KA, Lammertin G, Shroff SG, Pan L, Sun Y, Thury MJ, Lang RM, Ober C. Genetic determinants of cardiac contractility: a genome-wide association study. J Am Coll Cardiol 2008;51: A127

Sweis RN, Berry JD, Dyer AR, Cai X, Garside DB, Lloyd-Jones DM. Lifetime risk for cardiovascular disease by weight and metabolic syndrome status in men and women at selected ages. Circulation 2008;117:e231.

Tongers J, Webber MJ, Renault M-A, Roncalli JG, Stupp SI, Losordo DW. RGDS-epitope presenting peptide Amphiphile Nanofibers enhance regenerative potency of cell-based strategies of ischemic tissue. Circulation 2008;118 (suppl 2):S509.

Walsh MN, Fonarow G, Yancy CW, Albert NM, Curtis A, Stough G, Gheorghiade M, Heywood JT, McBride M, Mehra M, O’Connor C, Reynolds D. The influence of electronic health records on quality of care for heart failure. Circulation 2008;118 (suppl 2):S714.

Wang NC, Konstam MA, Maggioni AP, Traver B, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Zannad F, Cook T, Zimmer C, O'Connor C, Miller AB, Gheorghiade M. Correlation of ejection fraction to early post-discharge sudden death and all-cause mortality in the EVEREST trial. J Card Fail 2008;14:S70-S71.

Wang NC, Konstam MA, Maggioni AP, Traver B, Burnett JC, Grinfeld LC, Swedberg K, Udelson JE, Zannad F, Cook T, Zimmer C, O'Connor C, Miller AB, Gheorghiade M. Post-discharge adjudicated outcomes in patients with implantable cardioverter-defibrillators in the EVEREST Trial. J Card Fail 2008;14:S72.

Wilkins JT, McDermott MM, Liu K, Chan C, Criqui M, Lloyd-Jones DM. Cross-sectional associations of arterial stiffness measures and ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2008; 118 (suppl 2):S810.

Wu E, Rodriguez JF, Ortiz-Perez JT, Lee DC. Semi-quantitative segmental scores is an accurate method in determining the size and extent of acute myocardial infarction. J Cardiovasc Magn Res 2008;10:A153.

Yancy CW, Fonarow GC, Albert NM, Curtis A, Gattis Stough W, Gheorghiade M, Heywood JT, McBride ML, Mehra M, O'Connor C,Reynolds D, Walsh MN. Significant gaps in adherence to guideline recommended adjunctive heart failure therapies among outpatient cardiology practices: findings from IMPROVE HF. J Card Fail 2008; 14:S87.

Zhao Q, McCarthy PM, Lang RM, Veronesi F, Sonne C, Kane BJ, Underwood S, Bonow RO, Rigolin, VH. Three dimensional assessment of geometric and dynamic changes in the mitral annulus following mitral valve repair. J Am Soc Echocardiogr 2008;21:559.